|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.976
|
Yeast Zebrafish |
|
cardiac muscle cell development
|
GO:0055013 |
39 |
0.954
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.953
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.950
|
Yeast |
|
wound healing
|
GO:0042060 |
157 |
0.935
|
Mouse |
|
striated muscle cell development
|
GO:0055002 |
125 |
0.888
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.864
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.860
|
|
|
skeletal muscle thin filament assembly
|
GO:0030240 |
2 |
0.846
|
|
|
cardiac myofibril assembly
|
GO:0055003 |
12 |
0.841
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.839
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.829
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.828
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.799
|
Mouse |
|
actin filament based movement
|
GO:0030048 |
23 |
0.785
|
|
|
skeletal myofibril assembly
|
GO:0014866 |
4 |
0.768
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.719
|
|
|
apical constriction
|
GO:0003383 |
4 |
0.707
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.666
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.658
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.640
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.600
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.596
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.578
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.542
|
|
|
actin mediated cell contraction
|
GO:0070252 |
15 |
0.537
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.513
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.482
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.467
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.461
|
|
|
cardiac cell development
|
GO:0055006 |
41 |
0.453
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.432
|
|
|
muscle cell fate specification
|
GO:0042694 |
1 |
0.428
|
|
|
sarcomere organization
|
GO:0045214 |
24 |
0.419
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.403
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.395
|
|
|
positive regulation of heart rate by epinephrine norepinephrine
|
GO:0001996 |
4 |
0.392
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.380
|
Mouse |
|
myotube differentiation
|
GO:0014902 |
105 |
0.372
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.371
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.334
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.333
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.329
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.324
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.322
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.312
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.301
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.299
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.295
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.287
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.286
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.271
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.261
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.253
|
Mouse |
|
lung development
|
GO:0030324 |
164 |
0.250
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.250
|
Mouse |
|
vascular smooth muscle contraction
|
GO:0014829 |
5 |
0.249
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.235
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.231
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.220
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.219
|
|
|
termination of rna polymerase i transcription
|
GO:0006363 |
2 |
0.197
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.194
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.183
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.183
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.181
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.181
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.173
|
|
|
ossification
|
GO:0001503 |
216 |
0.170
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.166
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.165
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.161
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.155
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.155
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.153
|
|
|
regulation of integrin mediated signaling pathway
|
GO:2001044 |
8 |
0.146
|
|
|
negative regulation of actin filament depolymerization
|
GO:0030835 |
9 |
0.136
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.134
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.134
|
|
|
heart process
|
GO:0003015 |
94 |
0.134
|
|
|
cell aging
|
GO:0007569 |
35 |
0.132
|
Yeast |
|
response to inorganic substance
|
GO:0010035 |
96 |
0.130
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.130
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.129
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.128
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.127
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.120
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.119
|
|
|
wound healing spreading of cells
|
GO:0044319 |
8 |
0.118
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.116
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.116
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.115
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.115
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.115
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.114
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.110
|
|
|
early endosome to late endosome transport
|
GO:0045022 |
2 |
0.108
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.108
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.102
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
53 |
0.098
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.097
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.096
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.095
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.093
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.093
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.092
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.092
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.087
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.085
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.085
|
|
|
coagulation
|
GO:0050817 |
78 |
0.083
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.083
|
|
|
regionalization
|
GO:0003002 |
337 |
0.081
|
|
|
peripheral nervous system axon regeneration
|
GO:0014012 |
2 |
0.080
|
|
|
regulation of actin filament depolymerization
|
GO:0030834 |
13 |
0.080
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.078
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.078
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.078
|
|
|
bone development
|
GO:0060348 |
120 |
0.077
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.076
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.074
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.073
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.072
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.072
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.070
|
|
|
negative regulation of endocytosis
|
GO:0045806 |
12 |
0.069
|
Mouse |
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.069
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.069
|
|
|
membrane raft assembly
|
GO:0001765 |
3 |
0.068
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.068
|
Mouse |
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.068
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.067
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.067
|
|
|
negative regulation of osteoblast differentiation
|
GO:0045668 |
30 |
0.067
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.066
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.066
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.066
|
|
|
renal system process
|
GO:0003014 |
48 |
0.065
|
|
|
cytokinesis
|
GO:0000910 |
17 |
0.065
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.065
|
|
|
ovulation
|
GO:0030728 |
15 |
0.065
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.062
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.062
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.062
|
|
|
cell division
|
GO:0051301 |
120 |
0.061
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.061
|
|
|
chronological cell aging
|
GO:0001300 |
1 |
0.060
|
Yeast |
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.060
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.059
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.059
|
Mouse |
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.059
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.058
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.057
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.057
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.057
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.056
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.055
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.054
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.054
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.054
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.053
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.053
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.052
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.052
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.052
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.051
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.050
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.050
|
|
|
renal system development
|
GO:0072001 |
225 |
0.050
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.049
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.049
|
|
|
cardiac muscle fiber development
|
GO:0048739 |
4 |
0.049
|
|
|
mesangial cell development
|
GO:0072143 |
4 |
0.049
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.049
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.049
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.049
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.048
|
|
|
transcription initiation from rna polymerase i promoter
|
GO:0006361 |
4 |
0.048
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.047
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.047
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.046
|
|
|
gland development
|
GO:0048732 |
330 |
0.046
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.044
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.044
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.044
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.044
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.044
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.044
|
Mouse |
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.043
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.043
|
|
|
midgut development
|
GO:0007494 |
4 |
0.043
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.042
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.042
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.042
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.041
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.041
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.041
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.041
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.040
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.040
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.040
|
|
|
retina vasculature morphogenesis in camera type eye
|
GO:0061299 |
10 |
0.040
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.039
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.039
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.039
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.039
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.039
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.038
|
|
|
response to uv a
|
GO:0070141 |
1 |
0.038
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.038
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.038
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.037
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.037
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.037
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.037
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.037
|
|
|
tube formation
|
GO:0035148 |
140 |
0.037
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.037
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.036
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.036
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.036
|
|
|
growth plate cartilage development
|
GO:0003417 |
14 |
0.036
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.036
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.036
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.036
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.036
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.036
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.035
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.035
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.035
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.035
|
Mouse |
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.035
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.034
|
|
|
epithelial cell proliferation involved in liver morphogenesis
|
GO:0072575 |
7 |
0.034
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.034
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.033
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.033
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.033
|
|
|
negative regulation of b cell receptor signaling pathway
|
GO:0050859 |
4 |
0.033
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.033
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.033
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.033
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.033
|
|
|
negative regulation of hepatocyte proliferation
|
GO:2000346 |
3 |
0.032
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.032
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.032
|
|
|
head morphogenesis
|
GO:0060323 |
34 |
0.032
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.032
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.032
|
Mouse |
|
keratinocyte development
|
GO:0003334 |
10 |
0.031
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.031
|
|
|
cartilage development involved in endochondral bone morphogenesis
|
GO:0060351 |
24 |
0.031
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.031
|
|
|
positive regulation of epithelial to mesenchymal transition
|
GO:0010718 |
13 |
0.031
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.031
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.031
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.031
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.030
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.030
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.030
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.030
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.030
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.030
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.030
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.030
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.030
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.030
|
|
|
skin development
|
GO:0043588 |
220 |
0.030
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.029
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.029
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.029
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.029
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.029
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.029
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.029
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.029
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.029
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.029
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.028
|
|
|
epiboly involved in wound healing
|
GO:0090505 |
8 |
0.028
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.028
|
|
|
establishment or maintenance of bipolar cell polarity
|
GO:0061245 |
21 |
0.028
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.027
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.027
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.027
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.027
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.027
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.027
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.027
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.027
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.027
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.027
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.026
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.026
|
|
|
mitotic cytokinesis
|
GO:0000281 |
4 |
0.026
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.026
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.026
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.026
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.026
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.026
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.026
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.026
|
|
|
tubulin complex biogenesis
|
GO:0072668 |
2 |
0.026
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.026
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.025
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.025
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.025
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.025
|
|
|
wound healing spreading of epidermal cells
|
GO:0035313 |
5 |
0.025
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.025
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.025
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.024
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.024
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.024
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.024
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.024
|
|
|
embryonic nail plate morphogenesis
|
GO:0035880 |
3 |
0.024
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.024
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.024
|
|
|
establishment of t cell polarity
|
GO:0001768 |
2 |
0.024
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.024
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.024
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.024
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.023
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.023
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.023
|
|
|
smooth muscle contraction
|
GO:0006939 |
44 |
0.023
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.023
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.023
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.023
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.023
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.023
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.023
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.022
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.022
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.022
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.022
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.022
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.022
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.022
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.022
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.022
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.021
|
|
|
extracellular matrix assembly
|
GO:0085029 |
12 |
0.021
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.021
|
|
|
cation transport
|
GO:0006812 |
399 |
0.021
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
28 |
0.021
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.021
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.021
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.021
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.021
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.021
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.021
|
|
|
epiboly
|
GO:0090504 |
8 |
0.020
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.020
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.020
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.020
|
|
|
response to estrogen
|
GO:0043627 |
24 |
0.020
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.020
|
|
|
amide transport
|
GO:0042886 |
138 |
0.020
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.019
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.019
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.019
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.019
|
|
|
tubulin complex assembly
|
GO:0007021 |
2 |
0.019
|
|
|
regulation of hepatocyte proliferation
|
GO:2000345 |
6 |
0.019
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.019
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.019
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.019
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.019
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.018
|
|
|
adherens junction assembly
|
GO:0034333 |
22 |
0.018
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.018
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.018
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.018
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.018
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.018
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.018
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.018
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.018
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.018
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.018
|
|
|
gonad development
|
GO:0008406 |
141 |
0.018
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.018
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.018
|
|
|
epithelial cell differentiation involved in mammary gland alveolus development
|
GO:0061030 |
4 |
0.018
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.017
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.017
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.017
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.017
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.017
|
|
|
regulation of heart rate by chemical signal
|
GO:0003062 |
4 |
0.017
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
3 |
0.017
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.017
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.017
|
|
|
chondroblast differentiation
|
GO:0060591 |
2 |
0.017
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.017
|
|
|
neuromuscular process controlling balance
|
GO:0050885 |
59 |
0.017
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.017
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.017
|
|
|
actin filament depolymerization
|
GO:0030042 |
15 |
0.017
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.017
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.016
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.016
|
Mouse |
|
establishment or maintenance of apical basal cell polarity
|
GO:0035088 |
21 |
0.016
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.016
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.016
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.016
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.016
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.016
|
|
|
regulation of bone mineralization
|
GO:0030500 |
31 |
0.016
|
|
|
glycerophospholipid biosynthetic process
|
GO:0046474 |
32 |
0.016
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
30 |
0.016
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.016
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.016
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.016
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.016
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.016
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.016
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.015
|
|
|
renal system vasculature development
|
GO:0061437 |
15 |
0.015
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.015
|
|
|
liver development
|
GO:0001889 |
66 |
0.015
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.015
|
|
|
positive regulation of sphingolipid biosynthetic process
|
GO:0090154 |
1 |
0.015
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.015
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.015
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.015
|
|
|
multicellular organismal metabolic process
|
GO:0044236 |
28 |
0.015
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.015
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.015
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.015
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.015
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.015
|
|
|
regulation of lamellipodium assembly
|
GO:0010591 |
3 |
0.015
|
|
|
negative regulation of protein depolymerization
|
GO:1901880 |
21 |
0.015
|
|
|
positive regulation of integrin mediated signaling pathway
|
GO:2001046 |
5 |
0.015
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.015
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.015
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.015
|
|
|
protein import
|
GO:0017038 |
101 |
0.015
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.015
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.015
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.015
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.015
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.015
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.015
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.015
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.015
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.015
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.014
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.014
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.014
|
|
|
nail development
|
GO:0035878 |
5 |
0.014
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.014
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.014
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.014
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
26 |
0.014
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.014
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.014
|
|
|
response to uv
|
GO:0009411 |
44 |
0.014
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.014
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.014
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.014
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.014
|
|
|
positive regulation of ossification
|
GO:0045778 |
47 |
0.014
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.014
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
4 |
0.014
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.014
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.014
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.014
|
|
|
action potential
|
GO:0001508 |
78 |
0.014
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.014
|
|